OtherArticle
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived PDK-1 Inhibitor
Ping-Hui Tseng, Shu-Chuan Weng, Yu-Chieh Wang, Jing-Ru Weng, Chang-Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak and Ching-Shih Chen
Molecular Pharmacology August 3, 2006, DOI: https://doi.org/10.1124/mol.106.023911
Ping-Hui Tseng
Shu-Chuan Weng
Yu-Chieh Wang
Jing-Ru Weng
Chang-Shi Chen
Robert W. Brueggemeier
Charles L. Shapiro
Ching-Yu Chen
Sandra E. Dunn
Michael Pollak
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived PDK-1 Inhibitor
Ping-Hui Tseng, Shu-Chuan Weng, Yu-Chieh Wang, Jing-Ru Weng, Chang-Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak and Ching-Shih Chen
Molecular Pharmacology August 3, 2006, DOI: https://doi.org/10.1124/mol.106.023911
OtherArticle
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived PDK-1 Inhibitor
Ping-Hui Tseng, Shu-Chuan Weng, Yu-Chieh Wang, Jing-Ru Weng, Chang-Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak and Ching-Shih Chen
Molecular Pharmacology August 3, 2006, DOI: https://doi.org/10.1124/mol.106.023911
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement